Back
Genscript Biotech Corp. 10K Form
Sell
40
GNNSF
Genscript Biotech Corp.
Last Price:
$2.12
Seasonality Move:
30.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNNSF News And Ratings
See the #1 stock for the next 7 days that we like better than GNNSF
GNNSF Financial Statistics
Sales & Book Value
| Annual Sales: | $599.2M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 45.07 |
| Annual Sales: | $2.02 |
| Price / Book: | 1.1 |
Profitability
| EPS (TTM): | -0.01180 |
|---|---|
| Net Income (TTM): | $3B |
| Gross Margin: | $276.8M |
| Return on Equity: | 108.47% |
| Return on Assets: | 74.06% |
Genscript Biotech Corp. Earnings Forecast
Key Genscript Biotech Corp. Financial Ratios
-
The Gross Profit Margin over the past 13 years for GNNSF is 46.20%.
-
The Selling, General & Administrative Expenses for GNNSF have been equal to 33.80% of Gross Profit Margin.
-
The Research & Development expenses have been 8.98% of Revenue.
-
The Net Earning history of GNNSF is -29.00% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Genscript Biotech Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | GNNSF |
| Website: | genscript.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 2.72 |
| Quick Ratio: | 2.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.61 |
|---|---|
| Forward P/E Ratio: | 0 |
GNNSF Technical Analysis vs Fundamental Analysis
Sell
40
Genscript Biotech Corp. (GNNSF)
is a Sell
Is Genscript Biotech Corp. a Buy or a Sell?
-
Genscript Biotech Corp. stock is rated a SellThe current Genscript Biotech Corp. [GNNSF] share price is $2.12. The Score for GNNSF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.